» Articles » PMID: 27582153

Gestational Diabetes Mellitus in South Asia: Epidemiology

Overview
Journal J Pak Med Assoc
Specialty General Medicine
Date 2016 Sep 2
PMID 27582153
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Gestational diabetes mellitus, is defined by the American Diabetes Association as "diabetes diagnosed in the second or third trimester of pregnancy that is not clearly overt diabetes". WHO has further classified the period of diagnosis as Hyperglycaemia in Pregnancy and Gestational Diabetes Mellitus. The former term is applicable in the early period of gestation and GDM is detected after 24 weeks. Irrespective of the guidelines followed, the presence of Diabetes Mellitus during pregnancy, has to be taken seriously as it is an important metabolic derangement and can prove to be harmful for the mother and dangerous for the foetus. The rising incidence of Type 2 Diabetes Mellitus in the world along with obesity, is a major contributing factor for GDM. The trend of this rise is more steep in the low and middle income countries thus proportionately increasing the risk for GDM. South Asia falls in this bracket and the responsible factors have to be identified and corrected. Management should begin from primordial prevention for which education is a key factor. Every woman should be taught the way to follow a healthy life style. Identification of the contributing factors and universal screening facilities for all pregnant women living in both rural and urban areas, should be given prime importance. On detecting Hyperglycaemia in Pregnancy or GDM, monitoring and health care facilities should be provided. This review provides some available figures of GDM in South Asia, the risk factors in this population and the steps for prevention.

Citing Articles

Serum progesterone, glycosylated hemoglobin and insulin levels with the risk of premature rupture of membranes in gestational diabetes mellitus.

Zhou L, Xiong X, Chen L Clinics (Sao Paulo). 2024; 79:100461.

PMID: 39216124 PMC: 11402384. DOI: 10.1016/j.clinsp.2024.100461.


The role of machine learning algorithms in detection of gestational diabetes; a narrative review of current evidence.

Kokori E, Olatunji G, Aderinto N, Muogbo I, Ogieuhi I, Isarinade D Clin Diabetes Endocrinol. 2024; 10(1):18.

PMID: 38915129 PMC: 11197257. DOI: 10.1186/s40842-024-00176-7.


Designing and Developing a Mobile App for Management and Treatment of Gestational Diabetes in Nepal: User-Centered Design Study.

Shanmugavel A, Shakya P, Shrestha A, Nepal J, Shrestha A, Daneault J JMIR Form Res. 2024; 8:e50823.

PMID: 38231562 PMC: 10831589. DOI: 10.2196/50823.


Effects of insulin aspart and metformin on gestational diabetes mellitus and inflammatory markers.

Wang Y, Song M, Qi B World J Diabetes. 2023; 14(10):1532-1540.

PMID: 37970132 PMC: 10642422. DOI: 10.4239/wjd.v14.i10.1532.


The Relationship between Coronary Flow Reserve and the TyG Index in Patients with Gestational Diabetes Mellitus.

Ozyildirim S, Barman H, Dogan O, Ersanli M, Dogan S Medicina (Kaunas). 2023; 59(10).

PMID: 37893529 PMC: 10608421. DOI: 10.3390/medicina59101811.